Literature DB >> 18161883

Combination of photodynamic therapy and immunomodulation: current status and future trends.

Yong-Gang Qiang1, Christine M N Yow, Zheng Huang.   

Abstract

Photodynamic therapy (PDT) has been used for the treatment of nonmalignant and malignant diseases from head to toe. Over the last decade its clinical application has gained increasing acceptance around the world. Pre-clinical studies demonstrate that, in addition to the direct local cytotoxicity and vascular effects, PDT can induce various host immune responses. Recent clinical data also show that improved clinical outcomes are obtained through the combination of PDT and immunomodulation. This review will summarize and discuss recent progress in developing innovative regimen of PDT combined with immunomodulation for the treatment of both nonmalignant and malignant diseases. (c) 2007 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18161883      PMCID: PMC2561284          DOI: 10.1002/med.20121

Source DB:  PubMed          Journal:  Med Res Rev        ISSN: 0198-6325            Impact factor:   12.944


  81 in total

Review 1.  Photodynamic therapy and anti-tumour immunity.

Authors:  Ana P Castano; Pawel Mroz; Michael R Hamblin
Journal:  Nat Rev Cancer       Date:  2006-07       Impact factor: 60.716

Review 2.  Photodynamic therapy of microbial infections: state of the art and perspectives.

Authors:  Giulio Jori
Journal:  J Environ Pathol Toxicol Oncol       Date:  2006       Impact factor: 3.567

Review 3.  Elimination of alloreactive T cells using photodynamic therapy.

Authors:  R Sidi Boumédine; D C Roy
Journal:  Cytotherapy       Date:  2005       Impact factor: 5.414

4.  A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer.

Authors:  Boleslav Kosharskyy; Nicolas Solban; Sung K Chang; Imran Rizvi; Yuchiao Chang; Tayyaba Hasan
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

5.  Triple therapy for choroidal neovascularization due to age-related macular degeneration: verteporfin PDT, bevacizumab, and dexamethasone.

Authors:  Albert J Augustin; Stephan Puls; Indre Offermann
Journal:  Retina       Date:  2007-02       Impact factor: 4.256

Review 6.  Photosensitizer-antibody conjugates for detection and therapy of cancer.

Authors:  G A M S van Dongen; G W M Visser; M B Vrouenraets
Journal:  Adv Drug Deliv Rev       Date:  2004-01-13       Impact factor: 15.470

7.  Verteporfin therapy and intravitreal bevacizumab combined and alone in choroidal neovascularization due to age-related macular degeneration.

Authors:  Ratimir Lazic; Nikica Gabric
Journal:  Ophthalmology       Date:  2007-06       Impact factor: 12.079

8.  Internalisation enhances photo-induced cytotoxicity of monoclonal antibody-phthalocyanine conjugates.

Authors:  M Carcenac; M Dorvillius; V Garambois; F Glaussel; C Larroque; R Langlois; N E Hynes; J E van Lier; A Pèlegrin
Journal:  Br J Cancer       Date:  2001-11-30       Impact factor: 7.640

9.  The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy.

Authors:  R Hudson; M Carcenac; K Smith; L Madden; O J Clarke; A Pèlegrin; J Greenman; R W Boyle
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

10.  Role of cytokines in photodynamic therapy-induced local and systemic inflammation.

Authors:  S O Gollnick; S S Evans; H Baumann; B Owczarczak; P Maier; L Vaughan; W C Wang; E Unger; B W Henderson
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

View more
  10 in total

1.  Pheophorbide a-Mediated Photodynamic Therapy Triggers HLA Class I-Restricted Antigen Presentation in Human Hepatocellular Carcinoma.

Authors:  Patrick Ming-Kuen Tang; Ngoc-Ha Bui-Xuan; Chun-Kwok Wong; Wing-Ping Fong; Kwok-Pui Fung
Journal:  Transl Oncol       Date:  2010-04       Impact factor: 4.243

2.  Differential Immunomodulatory Activities of Schiff Base Complexes Depending on their Metal Conjugation.

Authors:  Furkan Ayaz; İlyas Gonul; Burcu Demirbag; Kasim Ocakoglu
Journal:  Inflammation       Date:  2019-10       Impact factor: 4.092

3.  Immune stimulating photoactive hybrid nanoparticles for metastatic breast cancer.

Authors:  Sean Marrache; Joshua H Choi; Smanla Tundup; Dhillon Zaver; Donald A Harn; Shanta Dhar
Journal:  Integr Biol (Camb)       Date:  2013-01       Impact factor: 2.192

Review 4.  Nanoparticle-mediated drug delivery for treating melanoma.

Authors:  Vaibhav Mundra; Wei Li; Ram I Mahato
Journal:  Nanomedicine (Lond)       Date:  2015-08-05       Impact factor: 5.307

Review 5.  Photodynamic therapy for treatment of solid tumors--potential and technical challenges.

Authors:  Zheng Huang; Heping Xu; Arlen D Meyers; Ali I Musani; Luowei Wang; Randall Tagg; Al B Barqawi; Yang K Chen
Journal:  Technol Cancer Res Treat       Date:  2008-08

6.  The efficacy and mechanism of apoptosis induction by hypericin-mediated sonodynamic therapy in THP-1 macrophages.

Authors:  Xuesong Li; Lei Gao; Longbin Zheng; Jiayuan Kou; Xing Zhu; Yueqing Jiang; Zhaoyu Zhong; Juhua Dan; Haobo Xu; Yang Yang; Hong Li; Sa Shi; Wenwu Cao; Yajun Zhao; Ye Tian; Liming Yang
Journal:  Int J Nanomedicine       Date:  2015-01-22

Review 7.  Photodynamic Antimicrobial Chemotherapy for Root Canal System Asepsis: A Narrative Literature Review.

Authors:  P Diogo; T Gonçalves; P Palma; J M Santos
Journal:  Int J Dent       Date:  2015-12-10

Review 8.  Derivatives of Natural Chlorophylls as Agents for Antimicrobial Photodynamic Therapy.

Authors:  Nikita Suvorov; Viktor Pogorilyy; Ekaterina Diachkova; Yuri Vasil'ev; Andrey Mironov; Mikhail Grin
Journal:  Int J Mol Sci       Date:  2021-06-15       Impact factor: 5.923

9.  The sonodynamic effect of curcumin on THP-1 cell-derived macrophages.

Authors:  Fengping Wang; Qianping Gao; Shuyuan Guo; Jiali Cheng; Xin Sun; Qiannan Li; Tengyu Wang; Zhiguo Zhang; Wenwu Cao; Ye Tian
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411

Review 10.  Current Therapeutics and Future Perspectives to Ocular Melanocytic Neoplasms in Dogs and Cats.

Authors:  Tarcísio Guerra Guimarães; Karla Menezes Cardoso; Pedro Tralhão; Carlos Miguel Marto; Nuno Alexandre; Maria Filomena Botelho; Mafalda Laranjo
Journal:  Bioengineering (Basel)       Date:  2021-12-20
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.